SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Diana, Princess of Wales — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientDiana Spencer
Date of birth1961-07-01
IdentifiersMRN HR-ML028-SYN-TD; SSN (made up) 000-28-5197
Document date1990-02-16
AuthorImogen Castleford, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

One-week review with potassium recheck, seen the same day by eating disorders psychiatry. [S]

History of Present Illness

Ms. Spencer returns one week after her first visit and is seen by Dr. Rosenthal, the eating disorders psychiatrist, on the same day. She has taken potassium chloride 20 mEq twice daily without stomach upset. She has kept the self-monitoring record she was given: seven episodes of binge eating with vomiting this week, from about ten, and breakfast on three days. She has met the dietitian once. She has had no palpitations, cramps, weakness, dizziness, or blood in the vomit. Her mood is still low and she is tired, but she says that telling someone has been a relief. She has had no thoughts of suicide or self-harm. [S]

ElementDetail
Binge eating and vomitingSeven episodes this week, from about ten
Potassium supplement20 mEq twice daily, every dose taken
Regular eatingBreakfast on three days; dietitian seen once
MoodLow; PHQ-9 13; item 9 scored 0

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired in the mornings; weight steady
CardiovascularNegativeNo palpitations, chest pain, or fainting
GastrointestinalPositiveVomiting after binges seven times this week; no blood in the vomit; no abdominal pain
MusculoskeletalNegativeNo cramps or weakness
PsychiatricPositiveLow mood and hopelessness, a little better; no thoughts of suicide or self-harm

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Potassium chloride 20 mEq extended-release oral tablet, one tablet by mouth twice daily with foodOne tablet by mouth twice daily with food, swallowed whole with a full glass of waterOral route1990-02-09 to 1990-03-16completedS
Fluoxetine 20 mg oral capsule, one capsule by mouth each morning for one week, then two capsules each morning for one weekOne capsule each morning for one week, then two capsules each morning for one weekOral route1990-02-16 to 1990-03-02completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1990-02-16Body height178cmS
1990-02-16Body weight61.2kgS
1990-02-16Body mass index (BMI) [Ratio]19.3kg/m2S
1990-02-16Systolic blood pressure104mm[Hg]S
1990-02-16Diastolic blood pressure66mm[Hg]S
1990-02-16Heart rate68/minS
1990-02-16Respiratory rate14/minS
1990-02-16Body temperature36.5CelS
1990-02-16Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1990-02-16Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1990-02-16Potassium [Moles/volume] in Serum or Plasma3.6mmol/L3.5-5.1 mmol/LNormalS
1990-02-16Chloride [Moles/volume] in Serum or Plasma99mmol/L98-107 mmol/LNormalS
1990-02-16Carbon dioxide, total [Moles/volume] in Serum or Plasma28mmol/L22-29 mmol/LNormalS
1990-02-16Creatinine [Mass/volume] in Serum or Plasma0.8mg/dL0.59-1.04 mg/dLNormalS
1990-02-16Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1985)/1.73 sq M103mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1990-02-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]13{score}S

Physical Exam

Vital signs recorded on 1990-02-16; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 61.2 kg, BMI 19.3; lying blood pressure 104/66 and pulse 68, standing 100/64 and pulse 84 after three minutes
Head and neckBoth parotid glands enlarged and non-tender, as before; enamel erosion on the inner surfaces of the upper front teeth
SkinSmall calluses on the backs of two knuckles of the right hand
PsychiatricTearful at times but engaged; organized; no psychotic features; insight good

Problems

ProblemClinical statusVerificationCodeProvenance
Bulimia nervosa, severe: recurrent binge eating, each time with self-induced vomiting, averaging about ten episodes a week for about three years, hidden from everyone; self-worth tied closely to body shape and weight; no laxatives, diuretics, diet pills, or excessive exercise. SCOFF 4 of 5; EDE-Q global score 3.9. Findings: bilateral parotid enlargement, enamel erosion on the inner surfaces of the upper front teeth, calluses on the backs of two knuckles of the right hand, a pulse rise of 22 per minute on standing, low potassium and chloride with a raised bicarbonate, and a raised amylase; BMI 19.3. Synthetic modern episode linked to her own public account of bulimiaactiveconfirmed F50.23S — Synthetic modern diagnosis by DSM-5-TR criteria; severity is graded by the average number of compensatory episodes a week (8 to 13 is severe).
Hypokalemia (potassium 3.1 mmol/L) with low chloride and metabolic alkalosis from repeated vomiting; QTc 452 ms; no palpitations, weakness, or faintingactiveconfirmed E87.6S — Synthetic presenting laboratory finding; resolved when potassium was normal on two checks.
Major depressive disorder, recurrent, moderate: about two months of low mood, tiredness, poor sleep, and feeling worthless and hopeless, with little pleasure in things she used to enjoy; PHQ-9 14 with item 9 scored 0; an earlier episode of depression after childbirth. Synthetic modern episode linked to her own public account of depressionactiveconfirmed F33.1S — Synthetic modern diagnosis; the earlier episode is the post-natal depression she described publicly.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyBinge-eating and vomiting frequency (her self-monitoring record)Every visitCompleted todaySeven episodes of binge eating with vomiting this week, from about ten
SurveyEating Disorder Examination Questionnaire (EDE-Q) global scoreBaseline, mid-treatment, and end of treatmentUp to dateGlobal score 3.9 at intake; repeat at mid-treatment
ExaminationWeight and BMIEvery visit, and weekly in CBT-E sessionsCompleted today61.2 kg, BMI 19.3
ExaminationLying and standing pulse and blood pressureEvery visit while purging continuesCompleted todayLying 104/66, pulse 68; standing 100/64, pulse 84 (rise 16)
LaboratoryPotassium, chloride, bicarbonate, and creatinineWeekly until potassium is normal twice, then at each medical visit while purging continuesCompleted todayPotassium 3.6 mmol/L, from 3.1; sodium 139, chloride 99, bicarbonate 28 mmol/L; creatinine 0.80 mg/dL, eGFR 103
LaboratoryMagnesium and phosphateBaseline, and again while potassium is lowUp to dateMagnesium 1.8 and phosphate 3.4 mg/dL at intake; magnesium again at the next visit
LaboratoryECG with QTcBaseline with purging or low potassium; after a QT-relevant medicine reaches its full dose while potassium has been lowDueQTc 452 ms at intake; repeat two weeks after reaching fluoxetine 60 mg
ExaminationParotid and dental examination; dental protectionEvery visit; a dental examination soon after diagnosis and regular dental reviews while vomiting continuesDueParotid enlargement and enamel erosion unchanged; dental examination advised at intake, not yet booked
Medication safetyOral potassium supplementWhile potassium is low or vomiting is frequentCompleted today20 mEq twice daily, every dose taken; continue until a second normal check
Medication safetyFluoxetine dose, adherence, and side effects (nausea, sleep, agitation, sexual effects, suicidal thoughts)At the start, one to two weeks after starting or a dose change, then every visitCompleted todayStarting today at 20 mg; side effects, agitation and suicidal thoughts explained; nurse phone check in ten days
ReferralEating disorders psychiatry consultationAt diagnosisCompleted todaySeen by Dr. Rosenthal today
Self-managementCBT-E attendance and progressUp to 20 sessions over 20 weeks, twice weekly for the first four weeksOrderedCBT-E starts this week
Self-managementRegular eating and dietitian reviewEvery visitCompleted todayBreakfast on three days; dietitian seen once
SurveyDepression measure (PHQ-9)Monthly during acute treatment, then periodicallyCompleted todayPHQ-9 13, item 9 scored 0
SurveySuicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; safety plan reviewed; no firearm
ExaminationLevel-of-care review against thresholds for urgent or inpatient careEvery visitCompleted todayOutpatient care remains safe: potassium above 3.0 mmol/L, QTc below 500 ms, no fainting, pulse above 50

Goal progress:

Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023); Eating disorders: recognition and treatment (NICE guideline NG69) (2017, updated 2020); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: CBT-E twice weekly from this week. Nurse phone check in ten days. Visit in four weeks with electrolytes, magnesium, ECG, and the PHQ-9. Next scheduled visit 1990-03-16: five-week review: potassium and ECG on fluoxetine 60 mg, CBT-E progress, mood, and safety. [S]